Bio€quity Europe 2025: our key takeaways Our key takeaways from the conference
Last week, the KBC Securities team attended the 25th Bio€quity Europe conference, taking place in Bruges, Belgium. The conference underscored a biotech industry navigating profound complexity, with recurring themes of geopolitical uncertainty, capital market volatility, and the growing influence of Asian innovation.
European biotech was portrayed as resilient and increasingly competitive, with McKinsey highlighting its strong scientific output, rising VC funding, and potential to capitalize on global disruption. Regulatory instability in the US, including FDA staffing issues and drug pricing r...